IACH Focus on Leukemia 2020 | Hot topics in CAR T-cell therapy for ALL
Christian Chabannon
• 1 Oct 2020
Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses the areas that research on CAR T-cell therapy should focus on. To improve clinical performance, CAR T-cell research needs to focus on defining the mechanisms of resistance. In addition to designing CAR-T cells that are more efficient at targeting different antigens. This interview took place during the 2020 Annual Meeting of the International Academy for Clinical Hematology (IACH).
Disclosures
Sanofi SA, Kite / Gilead, Novartis, Celgene / BMS, Janssen, Bellicum Pharmaceuticals, Terumo BCT: speakers bureau & advisory boards
